John Mark Bugarin Gubatan, MD
Gastroenterology · Jacksonville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Mayo Clinic Jacksonville · 1,595 clinicians in this group
Hospitals listed: Mayo Clinic · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gubatan’s office at (904) 953-2000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A154629 · Current
Licensed to practise in California · since 2018 · expires 2027-06-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mayo ClinicJacksonville, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Mayo Clinic Health System, which runs 26 hospitals in 5 statesHome of Mayo Clinic Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 89% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 117.75 (84.24 to 151.26) · 336 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 6.42 (3.82 to 9.02) · 3,723 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 3.53 (1.93 to 5.13) · 3,936 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.421, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.603, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.286, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.215, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Mayo Clinic
Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 117.75 (84.24 to 151.26) · 336 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.42 (3.82 to 9.02) · 3,723 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.53 (1.93 to 5.13) · 3,936 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.421 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.603 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.286 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.215 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.64 (0.01 to 1.27) · 4,881 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.78 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 857 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.2 · 1,110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 456 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 4,562 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.1 (0 to 0.27) · 15,533 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.09 to 0.41) · 17,711 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.22 (2.98 to 5.46) · 6,068 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0.64 to 2.25) · 3,974 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (2.03 to 3.96) · 4,959 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.71 to 3.09) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0.55 to 1.3) · 13,615 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 60 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 1.19 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.2 · 151 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 842 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 16.8 · 182 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6.5 · 1,022 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 0.2 · 1,203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 991 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.3 to 7.7) · 133 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.6 to 13.6) · 133 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (11.2 to 16.8) · 3,215 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 3,357 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,683 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 87% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 89% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$38,645
Medicare paid this office $38,645 for 149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,677 | $154 |
| Long return visit (40+ min) | 38 | $7,444 | $143 |
| Biopsy of large bowel using a flexible endoscope | 25 | $3,144 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,446 | $116 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,534 | $102 |
See all 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,677 | $154 |
| Long return visit (40+ min) | 38 | $7,444 | $143 |
| Biopsy of large bowel using a flexible endoscope | 25 | $3,144 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,446 | $116 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,534 | $102 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,382 | $92 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,310 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,264 | $105 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 16 | $68 | $4 |
Procedures Medicare counted
| Colonoscopy | 79 | More than 74% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 92 | More than 75% of doctors who do this |
Who their Medicare patients are
149 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 12% · Women 56% · Also on Medicaid 34% · Health risk score 2.34. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 40% · Chronic kidney disease 38% · Diabetes 37% · Depression 32% · Heart failure 30% · Atrial fibrillation 28% · Cancer 27% · COPD 19% · Stroke 16% · Dementia 15%.
The office billed $342,685, Medicare allowed $48,998 and paid $38,645; for 298 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 149 | 298 | 72 | 2.34 | $342,685 | $38,645 |
| 2023 | 163 | 327 | 71 | 2.01 | $382,012 | $41,299 |
| 2022 | 116 | 224 | 71 | 2.06 | $210,375 | $27,024 |
| 2021 | 31 | 64 | 68 | 1.91 | $55,398 | $8,163 |
| 2018 | 144 | 150 | 79 | 2.00 | $90,644 | $25,142 |
| 2017 | 104 | 106 | 80 | 1.97 | $50,174 | $16,576 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,402 | $156 |
| Long return visit (40+ min) | 33 | $5,218 | $119 |
| Biopsy of large bowel using a flexible endoscope | 33 | $4,273 | $129 |
| New patient visit (60+ min) | 17 | $2,809 | $165 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,718 | $227 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,605 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,519 | $117 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,260 | $97 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $76 | $4 |
2022: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,983 | $178 |
| Long return visit (40+ min) | 27 | $4,079 | $120 |
| Biopsy of large bowel using a flexible endoscope | 23 | $3,276 | $142 |
| New patient visit (60+ min) | 19 | $2,897 | $152 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,362 | $97 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 26 | $111 | $4 |
2021: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,792 | $186 |
2018: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $20,799 | $173 |
| Initial hospital observation care per day, typically 70 minutes | 29 | $4,256 | $147 |
2017: 2 services
| Initial hospital observation care per day, typically 70 minutes | 76 | $12,020 | $156 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,086 | $170 |
Drugs they prescribed that Part D paid
$536,552
Pharmacies billed $536,552 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 267) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
191 generic and 76 brand-name prescriptions · $536,552 in drug cost · 22 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 11 | $5,658 | $514 |
| Mesalamine | 14 | $5,451 | $389 |
| Colestipol | 45 | $3,223 | $72 |
| Peg 3350-Electrolyte | 18 | $306 | $17 |
| Omeprazole | 21 | $152 | $7 |
See all 6 drugs
| Linzess | 11 | $5,658 | $514 |
| Mesalamine | 14 | $5,451 | $389 |
| Colestipol | 45 | $3,223 | $72 |
| Peg 3350-Electrolyte | 18 | $306 | $17 |
| Omeprazole | 21 | $152 | $7 |
| Ciprofloxacin | 11 | $49 | $4 |
Year by year
| 2024 | 267 | 67 | 0% (0) | 28% | $536,552 |
| 2023 | 258 | 86 | 0% (0) | None | $418,932 |
| 2022 | 180 | 66 | None | None | $193,622 |
| 2021 | 58 | 19 | 0% (0) | 43% | $10,518 |
| 2020 | 59 | 19 | 0% (0) | None | $10,191 |
| 2019 | 44 | 13 | 0% (0) | None | $4,097 |
| 2017 | 193 | 33 | None | 20% | $12,592 |
| 2016 | 329 | 61 | None | 18% | $17,036 |
| 2015 | 232 | 50 | 5% (12) | None | $16,153 |
| 2014 | 85 | 18 | 13% (11) | 28% | $4,291 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Humira(Cf) | 13 | $346,010 | $26,616 |
| Creon | 14 | $10,973 | $784 |
| Mesalamine | 15 | $10,142 | $676 |
| Budesonide Ec | 14 | $6,662 | $476 |
| Colestipol | 19 | $1,200 | $63 |
| Peg 3350-Electrolyte | 30 | $647 | $22 |
| Omeprazole | 30 | $625 | $21 |
| Gavilyte-G | 14 | $238 | $17 |
| Cyanocobalamin | 11 | $66 | $6 |
2022: 3 drugs
| Budesonide Dr | 11 | $1,017 | $92 |
| Peg 3350-Electrolyte | 29 | $600 | $21 |
| Omeprazole | 13 | $203 | $16 |
2021: 1 drug
| Linzess | 17 | $8,368 | $492 |
2017: 5 drugs
| Mirtazapine | 11 | $290 | $26 |
| Cyclobenzaprine | 12 | $271 | $23 |
| Tamsulosin | 14 | $196 | $14 |
| Lisinopril | 12 | $87 | $7 |
| Furosemide | 13 | $28 | $2 |
2016: 7 drugs
| Mirtazapine | 17 | $727 | $43 |
| Proair Hfa | 11 | $604 | $55 |
| Metoprolol | 11 | $453 | $41 |
| Levothyroxine | 19 | $334 | $18 |
| Atorvastatin | 17 | $332 | $20 |
| Pantoprazole | 18 | $209 | $12 |
| Lisinopril | 27 | $139 | $5 |
2015: 3 drugs
| Mirtazapine | 11 | $449 | $41 |
| Clopidogrel | 11 | $154 | $14 |
| Lisinopril | 23 | $137 | $6 |
Money from drug and device companies
$148 in 2023
| 2023 | 2 | 2 | None | $148 |
| 2019 | 1 | 1 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $109 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $39 | 1 payment
|
See all 2 published payments
| Abbvie | Meals · 2023-05-09 | Rinvoq | $109 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2023-05-08 | Entyvio | $39 |
See earlier years (2019)
2019: $102
| AbbVie | None | $102 | 1 payment
|
Professional record
- NPI
- 1215340674
- Licence
- CA A154629, MA 260473California A154629: Current · expires 2027-06-30
- Trained
- Harvard Medical School, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-06-03
- NPI last updated
- 2025-08-18
- NPI record certified
- 2025-08-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 330 Brookline Ave, Boston, MA, 02215 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.